pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
IRX-4204
Parkinson's Disease
Retinoid X receptor
Io Therapeutics Inc
0
catalysts
Preclinical
IS-101
InvisiMask
Coronavirus Disease 2019 (COVID-19)
InvisiShield Technologies Ltd
0
catalysts
Phase 1
ISB-2001
Refractory Multiple Myeloma
$ABBV
AbbVie Inc.
0
catalysts
← prev
page 110 of 271
next →
131
Pain
89
Neurology
1
Phase 1
ISM-3412
Solid Tumor
InSilico Medicine
0
catalysts
Phase 1
ISM-6331
Malignant Mesothelioma
InSilico Medicine
0
catalysts
Preclinical
ISM-9274
Solid Tumor
InSilico Medicine
0
catalysts
Phase 2
ISN-001
Diabetic Foot Ulcers
Anterogen Co Ltd
0
catalysts
ISOLYTE S PH 7.4
ISOLYTE S PH 7.4 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE)
B BRAUN
0
catalysts
Phase 2
ISP-001
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Immusoft Corp
0
catalysts
Preclinical
ISP-002
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Immusoft Corp
0
catalysts
ISTURISA
ISTURISA (OSILODROSTAT PHOSPHATE)
Recordati SpA
0
catalysts
Preclinical
ISX9-CPC
Cardiomyopathy
IPS Heart Inc
0
catalysts
Phase 1
ITI-1001
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
0
catalysts
Phase 1
ITI-3000
Merkel Cell Carcinoma
Immunomic Therapeutics Inc
0
catalysts
ITOVEBI
ITOVEBI (INAVOLISIB)
Genentech Inc
0
catalysts
Preclinical
ITR-2401
Androgenic Alopecia
Solipharma LLC
0
catalysts
IVABRADINE
IVABRADINE (IVABRADINE)
ANNORA PHARMA
0
catalysts
Phase 2
IVB-001
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)
Invictus Therapeutics Ltd
0
catalysts
Phase 1
IVB-003
Pancreatic Cancer
Invictus Therapeutics Ltd
0
catalysts
Phase 2
IVMED-80
Keratoconus
$GKOS
GLAUKOS Corp
0
catalysts
Phase 1
IVMED-85
Myopia
iVeena Delivery Systems Inc
0
catalysts
IVRA
IVRA (MELPHALAN HCL)
APOTEX
0
catalysts
Phase 2
IVS-3001
Epithelial Ovarian Cancer
Invectys SA
0
catalysts
Preclinical
IVT-8086
Osteosarcoma
Innova Therapeutics Inc
0
catalysts
Phase 2
IVW-1001
Keratoconjunctivitis Sicca (Dry Eye)
iView Therapeutics Inc
0
catalysts
Preclinical
IVW-1802
Myopia
iView Therapeutics Inc
0
catalysts
Preclinical
IXTV-100
Substance (Drug) Abuse
InterveXion Therapeutics LLC
0
catalysts
IZERVAY
IZERVAY (AVACINCAPTAD PEGOL SODIUM)
Astellas Pharma Inc
0
catalysts
Marketed
Iheezo
Iheezo (chloroprocaine [INN])
Local Anesthetic Effect
$HROW
HARROW, INC.
0
catalysts
Phase 3
IkT-001
Pulmonary Arterial Hypertension
$IKT
Inhibikase Therapeutics, Inc.
0
catalysts
